Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Infection and Public Health|March 27, 2026
Linezolid-associated adverse events and outcomes in the treatment of multidrug/rifampicin-resistant tuberculosis: A systematic review and meta-analysis of randomized controlled trialsMita Restinia, Jheng-Yan Wu, Fajri Gafar, et al.
The European Respiratory Journal|September 14, 2019
Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in the NetherlandsFajri Gafar, Natasha Van't Boveneind-Vrubleuskaya, Onno W Akkerman, et al.
International Journal of Antimicrobial Agents|May 16, 2024
Pharmacokinetics of standard versus high-dose rifampin for tuberculosis preventive treatment: A sub-study of the 2R2 randomized controlled trialFajri Gafar, Vycke Yunivita, Federica Fregonese, et al.
The Pediatric Infectious Disease Journal|September 21, 2018
Antituberculosis Drug-induced Liver Injury in Children: Incidence and Risk Factors During the Two-month Intensive Phase of TherapyFajri Gafar, Helmi Arifin, Yusri D Jurnalis, et al.
The Pediatric Infectious Disease Journal|September 23, 2024
Clinical Features, Adverse Events and Treatment Outcomes of Multidrug/Rifampicin-resistant Tuberculosis in Children and Adolescents: An Eight-year Retrospective Cohort Study in Bandung, IndonesiaHeda M Nataprawira, Fajri Gafar, Chindy A Sari, et al.
Clinical Pharmacokinetics|January 21, 2026
Therapeutic Drug Monitoring for Improving Tuberculosis Treatment Outcomes: A Scoping Review of Clinical StudiesAisya Rezki Noeriman, Sumarheni Sumarheni, Aliya Nur Hasanah, et al.
Archives of Disease in Childhood|June 29, 2021
Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitisRovina Ruslami, Fajri Gafar, Vycke Yunivita, et al.
Emerging Infectious Diseases|February 24, 2022
Treatment Outcomes of Childhood Tuberculous Meningitis in a Real-World Retrospective Cohort, Bandung, IndonesiaHeda M Nataprawira, Fajri Gafar, Nelly A Risan, et al.
The Journal of Antimicrobial Chemotherapy|March 9, 2024
Pharmacokinetics and pharmacodynamics of high-dose isoniazid for the treatment of rifampicin- or multidrug-resistant tuberculosis in IndonesiaVycke Yunivita, Fajri Gafar, Prayudi Santoso, et al.
The European Respiratory Journal|May 31, 2020
Towards elimination of childhood and adolescent tuberculosis in the Netherlands: an epidemiological time-series analysis of national surveillance dataFajri Gafar, Taichi Ochi, Natasha Van't Boveneind-Vrubleuskaya, et al.
Pageof 2